Skip to content

Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation Study

Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02916563
Enrollment
50
Registered
2016-09-27
Start date
2016-07-31
Completion date
2016-08-31
Last updated
2020-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

This study evaluates the performance of a blood glucose monitoring system at high altitudes (approximately 10,000 feet). The performance is assessed via a reference method for glucose analysis (Yellow Springs Instrument 2300 STAT Plus Glucose Analyzer).

Detailed description

This study will be a non-randomized study conducted to assess the accuracy and performance of the Dario Blood Glucose Monitoring System at an elevated altitude. 50 subjects will be enrolled in this study. Participation includes a 15-20 minute visit to the clinical site where they will be consented. The participant will then receive a fingerstick to obtain capillary blood used to test the performance of the BGMS and to obtain a comparative glucose measurement on the reference method, the Yellow Springs Instrument 2300 STAT Plus Glucose Analyzer.

Interventions

DEVICEBlood Glucose Monitoring System Altitude Performance

Performance as assessed against a reference method at an altitude of approximately 10,000 feet.

Sponsors

LabStyle Innovations Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Able to speak and read English

Exclusion criteria

* Pregnant * Has any condition that the principle investigator believes may interfere in the subject's participation in the trial.

Design outcomes

Primary

MeasureTime frameDescription
Number of Successful Glucose ReadingsOne dayThe success criterion for the performance of the Blood Glucose Monitoring System at high altitude (approximately 10,000 feet above sea level) means that 95% of the blood glucose readings fall within 15mg/dL of the YSI reference value (for reference values less than 75 mg/dL) and within 20% (for reference values greater than or equal to 75 mg/dL).

Countries

United States

Participant flow

Participants by arm

ArmCount
Individuals With Type 1 or Type 2 Diabetes and Individuals Without Diabetes
A total of 50 subjects diagnosed with type 1 or type 2 diabetes and individuals without diabetes. 1. Age of subject is 18 years or older 2. Able to speak and read English
50
Total50

Baseline characteristics

CharacteristicIndividuals With Type 1 or Type 2 Diabetes and Individuals Without Diabetes
Age, Continuous44.9 years
STANDARD_DEVIATION 18.5
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
28 Participants
Sex: Female, Male
Male
22 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 50
serious
Total, serious adverse events
0 / 50

Outcome results

Primary

Number of Successful Glucose Readings

The success criterion for the performance of the Blood Glucose Monitoring System at high altitude (approximately 10,000 feet above sea level) means that 95% of the blood glucose readings fall within 15mg/dL of the YSI reference value (for reference values less than 75 mg/dL) and within 20% (for reference values greater than or equal to 75 mg/dL).

Time frame: One day

Population: Each subject will be measured 9 times with the Dario system: 3 strips lots for each of the three representative smart mobile devices (total of nine meters) under evaluation (150 strips per mobile device, total no. of strips 450).

ArmMeasureValue (NUMBER)
Individuals With Type 1 or Type 2 Diabetes and Individuals Without DiabetesNumber of Successful Glucose Readings449 Number of Glucose readings in range

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026